| Stage | CMCSA | % of rev | GLIBK | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $29.3B | 100.00% | $261M | 100.00% | CMCSA ×112.25 |
| Gross profit | $21.8B | 74.35% | $261M | 100.00% | GLIBK +25.7pp |
| Operating income | $5.3B | 18.16% | $29M | 11.11% | CMCSA +7.0pp |
| Pre-tax income | $4.4B | 15.18% | $23M | 8.81% | CMCSA +6.4pp |
| Net income | $3.4B | 11.48% | $16M | 6.13% | CMCSA +5.3pp |
| Stage | CMCSA | GLIBK | Gap · A − B |
|---|---|---|---|
| Revenue | $29.3B100.00% | $261M100.00% | CMCSA ×112.25 |
| Gross profit | 74.35%$21.8B | 100.00%$261M | GLIBK +25.7pp |
| Operating income | 18.16%$5.3B | 11.11%$29M | CMCSA +7.0pp |
| Pre-tax income | 15.18%$4.4B | 8.81%$23M | CMCSA +6.4pp |
| Net income |
| 11.48%$3.4B |
| 6.13%$16M |
| CMCSA +5.3pp |
No disclosed counterparties: GLIBK.
None